Peripheral Blood Monocyte Abundance Predicts Outcomes in Breast Cancer Patients

Justin M. Balko; Margaret L. Axelrod; Yu Wang; Yaomin Xu; Xiaopeng Sun; Adrian Bejan; Paula I. González-Ericsson; Sara Nunnery; Riley Berhman; Joshua Donaldson; Ángel Guerrero‐Zotano; Chiara Massa; Barbara Seliger; Melinda Sanders; Ingrid Mayer

doi:10.21203/rs.3.rs-1017242/v1

Abstract

1 min read

Biomarkers of response are needed in breast cancer to stratify patients to appropriate therapies and avoid unnecessary toxicity. Peripheral blood gene expression and cell type abundance were used to identify biomarkers of response and recurrence in neoadjuvant chemotherapy treated breast cancer patients. Higher peripheral blood monocyte abundance after neoadjuvant chemotherapy was associated with improved prognosis in multiple independent cohorts of breast cancer patients.

Related publications

Article2022

Abstract P1-08-34: Peripheral immunity predicts therapeutic outcomes in breast cancer patients

Margaret L. Axelrod, Yu Wang, Yaomin Xu, Adrian Bejan, Xiaopeng Sun, Paula I. González-Ericsson, Riley E. Bergman, Joshua Donaldson, Sara Nunnery, Melinda Sanders, Chiara Massa, Barbara Seliger, Ingrid A. Mayer, Justin M. Balko

Cancer Research

Article2024

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

Sara Cabrero‐de las Heras, Xavier Hernández‐Yagüe, Andrea González, Ferrán Losa, Gemma Soler, Cristina Bugés, Iosune Baraibar, Anna Esteve, Miguel Ángel Pardo-Cea, Anne Hansen Ree, Neus Martínez-Bosch, Maria Nieva, Eva Musulen, Sebastian Meltzer, Tania Lobato, Carla Vendrell-Ayats, Cristina Queralt, Pilar Navarro, Clara Montagut, Ferran Grau‐Leal, David Camacho, Raquel Legido, Núria Mulet-Margalef, Eva Martinez‐Balibrea

Article2015

The recent progress of neoadjuvant chemotherapy in triple negative breast cancer: A short review

Michalis Liontos, Sophia Karageorgopoulou, Vasiliki Michalaki, John Contis, Evangelos Bournakis, John Vassiliou, Meletios A Dimopoulos, Christos Papadimitriou

Preprint2023

Data from Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk

Kevin F. Brennan, Montserrat García‐Closas, Nick Orr, Olivia Fletcher, Michael Jones, Alan Ashworth, Anthony J. Swerdlow, Heather Thorne, Elio Riboli, Paolo Vineis, Miren Dorronsoro, Francoise Clavel-Chapelon, Salvatore Panico, N. Charlotte Onland‐Moret, Dimitrios Trichopoulos, Rudolf Kaaks, Kay‐Tee Khaw, Robert Brown, James M. Flanagan

Preprint2023

Peripheral Blood Monocyte Abundance Predicts Outcomes in Breast Cancer Patients

Abstract

Discussion(0)

Open reviews(0)

Related publications

Abstract P1-08-34: Peripheral immunity predicts therapeutic outcomes in breast cancer patients

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

The recent progress of neoadjuvant chemotherapy in triple negative breast cancer: A short review

Data from Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk

Data from Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk